EIDP, Inc. · CTA-PA · FY2024 Q4 · Calendar Q1 2025
Corteva targets 2025 growth as technology adoption meets currency and pricing risks
Corteva's call framed its 2025 growth outlook around seed technology adoption, crop-protection and biological launches, licensing income, and productivity. The thesis is supported by management's confident tone and stated growth and margin targets, but remains exposed to foreign exchange, Latin American pricing and volume conditions, tariffs, and regulatory uncertainty.
Research this report with FN2. Free to start; review your question before sending.
Earnings scorecard
Reported versus consensusMarket reaction
unavailableAsk FN2 about CTA-PA FY2024 Q4
Choose a question to continue your researchFree to start. Your question opens in chat for you to review and send. FN2 can look up the transcript, financials and prior quarters.
Transcript intelligence
What changed
Compared with the prior-quarter analysis, the current-call analysis emphasized a full-year 2024 operating EBITDA margin milestone and an approximately 10% EBITDA-growth outlook for 2025, while maintaining guidance. It also highlighted Enlist E3 sales and penetration, stronger Q4 crop-protection margins in Brazil, and shareholder returns. The prior quarter had instead described lowered 2024 guidance in response to Latin American conditions and introduced the 2025 outlook.
Guidance delta
The current-call analysis says management maintained guidance and targets approximately 10% EBITDA growth and 100–150 basis points of margin expansion in 2025. The prior-quarter analysis had reported lower 2024 guidance and an initial 2025 outlook; the supplied analysis does not provide a quantified revision between those 2025 outlooks.
Key takeaways
- Management described 2024 operating EBITDA margin reaching 20% and crop-protection Q4 margin expansion.
- Management cited seed growth and Enlist E3 sales of $1.9 billion, with 65% penetration in US soybeans.
- The 2025 outlook targets approximately 10% EBITDA growth and 100–150 basis points of margin expansion, while anticipating currency headwinds.
- The call analysis cited $1.7 billion of free cash flow and $1.5 billion of shareholder returns in 2024.
- Planned growth levers include roughly 300 new seed hybrids, out-licensing, biologicals, and cost improvements.
Management priorities
- Launch roughly 300 new seed hybrids in 2025.
- Expand out-licensing of Enlist, Concessa, and Paracort traits.
- Grow biologicals, with a stated target of $1 billion in revenue by decade-end.
- Deliver $400 million of net cost improvements in 2025.
- Execute the stated $1 billion share-repurchase program in 2025.
Follow CTA-PA with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeCompany context
Snapshot as of publicationEIDP, Inc. is an agricultural enterprise focused on creating and providing commercial seed and crop protection products. Its operations span across a wide global area, encompassing the United States, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific region. The company's business is structured into two main divisions: Seed and Crop Protection. Through its Seed segment, EIDP, Inc. offers a variety of products including corn, soybean, and other oil seeds. This division also develops innovative trait technologies that enhance crops' natural defenses against challenging weather, diseases, insects, and herbicides used for weed control.…
Historical context
All CTA-PA earningsBasic Materials peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| SQM Sociedad Química y Minera de Chile S.A. | FY2026 Q3 · Calendar Q4 2026 | -3.0% | -5.5% | SQM Sees Lithium Demand Growth but Flags Price and Inventory Risks |
| CTA-PB EIDP, Inc. USD 4.50 Cum Pfd Registered Shs | FY2026 Q3 · Calendar Q3 2026 | — | — | New-product growth held up, but Brazil weakness cut the EBITDA outlook |
| VYLR Vylor Inc. | FY2026 Q3 · Calendar Q4 2026 | +21.1% | -0.1% | Vylor reaffirms 2026 outlook as Brazil licensing model shifts |
| CTVA Corteva, Inc. | FY2026 Q3 · Calendar Q4 2026 | +231.9% | -19.6% | Corteva Q3: New Products Grow as Brazil Weakness Cuts Outlook |
| FNV Franco-Nevada Corporation | FY2026 Q3 · Calendar Q4 2026 | +6.8% | -2.4% | Franco-Nevada Q3: stronger earnings, but revenue missed estimates |
Latest beats and misses
Who reports nextBeat on EPS
- INTUFY2027 Q1 · November 19, 2026+18.3% EPS-6.2% move
- ROSTFY2026 Q3 · November 19, 2026+2.1% EPS-2.8% move
- ESTCFY2027 Q2 · November 19, 2026+16.2% EPS+2.0% move
- KEYSFY2026 Q4 · November 19, 2026+7.1% EPS-1.5% move
- WSMFY2026 Q3 · November 19, 20260.0% EPS-15.2% move
- WMGFY2026 Q4 · November 19, 2026+50.9% EPS-0.6% move
Missed on EPS
- NTESFY2026 Q3 · November 19, 2026-12.8% EPS-11.4% move
- FUTUFY2026 Q3 · November 19, 2026-7.8% EPS+4.8% move
- BABAFY2027 Q2 · November 19, 2026-29.2% EPS-1.3% move
- SQMFY2026 Q3 · November 17, 2026-3.0% EPS-5.5% move
- VIKFY2026 Q3 · November 17, 2026-12.6% EPS+4.4% move
- XPFY2026 Q3 · November 16, 2026-3.0% EPS-2.5% move
Get the CTA-PA recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2025-01-23T00:02:36.799981+00:00
- Polygon adjusted daily market bars
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-11-13. For educational purposes only; not investment advice.